The Pharmaceutical Journal
Vol 271 No 7280 p840
20/27 December 2003

This page
Reprint
Photocopy

PDF* 75K

  Modernisation
  MHRA leaflet
  Aqueous cream
  CPD
  Ramipril
  Community pharmacy
  Fellowships
  Top-up fees
  Product names

Letters to the Editor

MHRA leaflet

Leaflet could be dangerous

From Mr M. Bennett, FRPharmS

I note your report (PJ, 29 November, p733) on the leaflet and posters being sent for distribution via pharmacies encouraging patients to report problems with medical devices and equipment direct to the Medical and Healthcare products Regulatory Agency (MHRA).

I consider that this leaflet could be dangerous. I believe that, in the first instance, the person should contact whoever supplied the item so that they are able to take immediate action. After that, if they are not satisfied that the problem has been dealt with correctly, they could then contact the MHRA.

In the past we have had instances where patients have reported a problem (more often than not due to incorrect use) where we have been able to attend almost immediately and resolve it. This is particularly important with power-driven wheelchairs and scooters where there is potential for a serious accident to occur.

The advice in the leaflet implies that the first response should be to contact the MHRA and, since an address is provided, it would not be unreasonable for a patient to consider posting the information. How long it will take for anything to happen is anyone’s guess.

Until the leaflet is amended to emphasise the need for patients to report any problems as soon as possible to whoever supplied the item, I will not be distributing them.

Martin Bennett
Associated Chemists (Wicker) Ltd,
Sheffield

Send your letter to The Editor

Previous Topic (Modernisation)
Next Topic (Aqueous cream)